William Edelman, acting CEO and Chairman of the Board

Bill EdelmanBill Edelman is a medical device industry executive with over 32 years experience and currently serves as the CEO of Highland Instruments.

Mr Edelman was most recently President & Chief Executive Officer, TYRX, Inc., a commercial stage venture backed medical device company focused in drug/device implant products for general surgery, electrophysiology and cosmetic surgery. Prior to TYRX, Mr. Edelman has held executive level positions at MicroSense International, LLC (bio-sensing), FibraSonics, Inc. (ultrasonic surgical products), NeuroMod, Inc. (neuro-stimulation technologies), St. Jude Medical, Inc. (NYSE: STJ), Pfizer, Inc. (NYSE: PFE), and Baxter International, Inc. (NYSE: BAX). LinkedIn Bio.

Timothy Wagner, CSO, Founder

Tim WagnerTim Wagner has over 15 years of experience in the neurotechnology space, and currently serves as the CSO of Highland Instruments.

Dr. Wagner has written or presented multiple peer reviewed publications, theses, and scientific talks focused on noninvasive brain stimulation. He is currently a Lecturer at MIT in the Division of Health Sciences and Technology and a Clinical instructor at Harvard Medical School. He was trained at Harvard Medical School and MIT's joint Health Sciences and Technology program with degrees in: Medical and Electrical Engineering (PhD, dual distinction) and Electrical Engineering and Computer Science (MS). NIH Biosketch LinkedIn Bio.


Principal Clinical Investigator

Felipe Fregni, MD, PhD, MPH (Spaulding Rehabilitation Hospital, Harvard Medical School)

Tim WagnerDr. Fregni is the Director of the Laboratory of Neuromodulation at Spaulding Rehabilitation Hospital and Assistant Professor of Neurology at Harvard Medical School.He is a pioneer in the world of noninvasive brain stimulation, having conducted instrumental trials exploring neuromodulation treatments for chronic pain, Parkinson's disease, and stroke. Laboratory of Neuromodulation.



Regulatory Affairs

Leo Basta, Regulatory Affairs

Leo Basta was a co-founder of Boston Biomedical Associates (BBA), a consulting firm that provides a full range of regulatory, quality assurance, and clinical research services to medical device and biomedical companies. At BBA, Leo was responsible for directing all consulting services for Regulatory Affairs and Quality Assurance.

Leo has over 25 years of experience from the medical device, in-vitro diagnostic, and pharmaceutical industries. Prior to founding BBA, Leo had a 13-year career with Boston Scientific Corporation (BSC), a multi-billion dollar corporation and major manufacturer of innovative medical devices.

As Director of Regulatory and Clinical Affairs at BSC, he was responsible for all phases of product development and approval, compliance activities, as well as developing policies and procedures relating to all aspects of medical device regulation. He was involved with the integration and management of regulatory and clinical responsibilities for five company acquisitions covering a wide range of therapeutic areas as well. Leo was pivotal in developing and refining the entire regulatory department beginning as Manager of Regulatory Affairs. Leo directed the strategy and submission of numerous regulatory submissions covering many therapeutic areas with specialization in stent and catheter technology.